Add BrightSurf on Google Email

Science News Archive 2018 - Page 40


Page 40 of 473

Trial of investigational Ebola treatments begins in Democratic Republic of the Congo

A randomized, controlled trial is enrolling patients with confirmed Ebola virus disease in the Democratic Republic of Congo to compare mortality among those receiving three investigational drugs with a control group. The trial aims to establish the safety and efficacy of these treatments in a comprehensive response to combat Ebola.

Early detection of epilepsy in children possible with deep learning computer science technique

Researchers developed a novel classification method combining brain imaging data from MRI and fMRI to recognize patients with benign epilepsy with centrotemporal spikes. This approach improved diagnosis accuracy, enabling early detection and treatment, which leads to better health outcomes for children. The study used a dataset of 40 B...

SourceGeorgia State University·JournalIET Computer Vision·DateNov 27, 2018

Hacking the aging code: Big data to the rescue

Researchers use big data from medical studies and large biobanks to develop models predicting biological age, aging rate, and potential targets for future anti-aging therapies. The approach also led to the identification of wearable-based biomarkers of aging and frailty.

SourceGero·JournalFrontiers in Genetics·DateNov 27, 2018

UA researchers help discover genetic factor that can help or hurt risk for heart disease

A team of UA researchers discovered a previously unknown genetic effect that can raise or reduce the risk of coronary artery disease or ischemic stroke. People with the beneficial version of the genetic factor have less inflammatory cells lining their blood vessels, making them more resistant to building up plaque.

SourceUniversity of Arizona Health Sciences·JournalProceedings of the National Academy of Sciences·DateNov 27, 2018

Why screen time can disrupt sleep

Salk scientists discovered that melanopsin cells, responsible for regulating consciousness and sleep, respond to prolonged illumination, but can become desensitized. The study may lead to new treatments for migraines, insomnia, jet lag and circadian rhythm disorders.

SourceSalk Institute·JournalCell Reports·DateNov 27, 2018

New device could monitor anticoagulant treatments with to deliver personalized therapies

A new biosensor device uses gold nanostructures to detect the presence of anticoagulant drugs like Sintrom, enabling personalized therapy adjustments. This technology has significant potential for patients with cardiovascular diseases or thromboembolic disorders, who often face risks associated with incorrect medication dosing.

SourceSpanish National Research Council (CSIC)·JournalBiosensors and Bioelectronics·DateNov 26, 2018